Medicana Health Group, a leader in holistic healthcare provision, is set to make its mark in the UK, responding to the increasing demand for premium healthcare services.
With a reputation for integrated healthcare excellence, Medicana Health Group announces its expansion into the UK, bringing with it a patient-first approach and customised care solutions. This initiative is aimed at meeting the rising preference for private healthcare and insurance in the post-COVID landscape. Medicana’s guiding principle of “active listening and personalised attention” is geared towards fully understanding and addressing the unique needs of each patient, thus promising a tailored healthcare pathway from the initial consultation to aftercare, aiming to revolutionise the UK’s private healthcare sector.
By adhering to “active listening and personalised attention at every stage of the patient’s journey,” Medicana Health Group is dedicated to ensuring a patient experience that is both highly personalised and strategically planned, reflecting their tried-and-tested approach in Türkiye to innovate the UK’s private healthcare offerings.
Delving into the £282 Billion UK Healthcare Market
The resurgence of the UK’s private healthcare sector in the aftermath of COVID-19 has been notably driven by an uptick in individuals opting for self-funded healthcare solutions. An unprecedented number of individuals are now turning to private healthcare to bypass the NHS’s lengthy queues and access the superior quality and expertise of the independent sector. The Akeso report estimates the UK’s healthcare expenditure in 2022 at approximately £282 billion, with a split of around 80% public spending and 20% private spending.
In this burgeoning market, Medicana plans to leverage its deep expertise and comprehensive care offerings to penetrate the UK’s private healthcare landscape. Introducing its proven model of care, which encompasses everything from advanced diagnostics to tailored treatments, Medicana is set to satisfy the increasing demand for top-tier private healthcare. The group’s unwavering commitment to healthcare excellence, coupled with its innovative patient care approach, makes Medicana a suitable solution to the UK’s current healthcare challenges.
Serving Over 5.5 Million Patients Annually
Annually, Medicana Health Group provides exceptional healthcare to over 5.5 million patients around the world, facilitated by its 16 hospitals with substantial bed capacities. This highlights their vast experience in delivering high-quality care and their capability to meet the complex needs of a global patient population. The expansion of Medicana Health Group into the UK is expected to bring about a significant transformation towards more compassionate, efficient, and personalised healthcare, marking a new milestone in their ongoing commitment to enhancing patient welfare and global healthcare standards.
With a rich history of over 30 years, Medicana’s expertise spans a wide array of medical specialities, providing cutting-edge services in fields such as Oncology, Surgical Oncology, Organ and Bone Marrow Transplantation, Neurosurgery, In Vitro Fertilisation (IVF), Genetics, Cardiovascular Surgery, Orthopaedics and Traumatology, and Obesity Surgery. Since 2016, Medicana Health Group has further extended its reach into education, offering a wide range of educational programmes from early childhood education to university level, both in Türkiye and internationally.